Exchange: OTC·Updated 07:52 AM EDT

BSEM Biostem Technologies Inc

$1.57
$0.0307
(1.99%)
Pre-Market
Prev Close $1.54
Reported EarningsAug 12
Mkt Cap$28.76M
Vol3,010.00

About BSEM

BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. It offers pre-treatment assessment, cell therapies, anti-aging, and wellness compounds. The company was founded by Andrew Smith Van Vurst, Henry W. Van Vurst IV, and Jason Matuszewski on April 29, 1939 and is headquartered in Pompano Beach, FL.
48

Neutral Sentiment

How do you feel about BSEM?

Advertisement|Remove ads.